Our Approach
Redefining Autoimmunity
We partner with leading clinical researchers and laboratory professionals to deliver breakthrough after breakthrough. Each one helps improve care for millions of patients living with autoimmune diseases through enhanced quality and efficiency.
What’s our latest breakthrough?
QUANTA Flash HMGCR help diagnose a form of statin-associated necrotizing myopathy which is positive by anti-HMGCR and not usually detected by other myopathy/myositis biomarkers.
How are we advancing the quality and efficiency of autoimmune testing?
NOVA Lite DAPI reagents, used in combination with NOVA View, provide improved quality for IFA testing with an automated process that can reduce labor hours and hands-on time in the lab.
How do we increase detection rates for APS?
QUANTA Lite anti-PS/PT is designed to increase detection rates for diagnosing APS by improving sensitivity, without sacrificing specificity. It can even be used to aid diagnosis when patients have already started treatment with anti-coagulation therapy.
REAGENTS AND SYSTEMS
Innovators in autoimmune testing
Whether you're looking for more accurate results, or you want to increase efficiency in your lab, you can trust our systems and reagents to serve your needs.
NEWS & EVENTS
Keep track of the latest developments.
Check out our latest news and events in autoimmune diagnostics from all over the world.
May 10, 2021 - San Diego
QUANTA Flash® SARS-CoV-2 IgG Receives Emergency Use Authorization from FDA
February 23, 2021 - San Diego
NOVA Lite® DAPI dsDNA Crithidia luciliae Kit for NOVA View® Receives FDA Clearance
CAREERS
It All Starts With People
Our talent is, without a question, our most important asset. Our employees are the face of Inova, and they represent our values in their day-to-day interactions with our stakeholders
